| Dr Lonnie Joan Lee, MD | |
|
6525 Belcrest Road, Suite 160, Hyattsville, MD 20782-2003 | |
| (301) 209-6218 | |
| (301) 209-6284 |
| Full Name | Dr Lonnie Joan Lee |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 6525 Belcrest Road, Hyattsville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992866271 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lonnie Joan Lee, MD 2101 East Jefferson Street, Ppqa Medicare Compliance Unit 6 W Attn Theresa Brooks, Rockville, MD 20852-4908 Ph: (301) 816-6660 | Dr Lonnie Joan Lee, MD 6525 Belcrest Road, Suite 160, Hyattsville, MD 20782-2003 Ph: (301) 209-6218 |
News Archive
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
MICRALOX, a revolutionary new aluminum oxide coating for finishing aluminum medical devices, is being launched into the global marketplace by the Sanford Process Corporation (SPC), a wholly owned subsidiary of Duralectra-CHN.
A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug-resistant epilepsies, and in particular, childhood epilepsies.
Roche announced today, that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.
› Verified 6 days ago
Dr. Joshua Ruffin Holloway, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6525 Belcrest Rd, Prince George's Medical Center, Hyattsville, MD 20782 Phone: 301-209-6000 Fax: 301-209-6023 | |
Jennifer Yee Prendez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6525 Belcrest Rd, Hyattsville, MD 20782 Phone: 301-209-6000 | |
Dr. Chevonne Tenille Salmon-ray, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6525 Belcrest Rd, Kaiser Permanente Prince George's Medical Center, Hyattsville, MD 20782 Phone: 301-209-6000 | |
Dr. Sandra Yvonne Robinson-redway, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3331 Toledo Terrace, Suite 107, Hyattsville, MD 20782 Phone: 301-559-0151 Fax: 301-559-2932 | |
Dr. Ellen Dena Finkelman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6525 Belcrest Road, Suite 160, Hyattsville, MD 20782 Phone: 301-209-6155 Fax: 301-209-6206 | |
Dr. Claudia K Donovan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4000 Garden City Dr, Hyattsville, MD 20785 Phone: 240-839-0489 Fax: 301-552-1238 | |
Dr. Gabriel B Spring, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8201 Corporate Dr Ste 650, Hyattsville, MD 20785 Phone: 504-321-4444 |